← Back to All Filings

Roivant Sciences Director James C. Momtazee Disposes Shares for Tax Withholding

Low SignificanceSeptember 14, 2026 at 10:37:55 PM UTC

Roivant Sciences Ltd.

$ROIV4CIK: 0001635088

Subscribe to track ROIV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Roivant Sciences Ltd. ($ROIV) Form 4 Filing Insider: James C. Momtazee (Director) Transaction: Net Settlement / Tax Withholding (Code F) Shares: 2,905 Common Shares @ $40.94 (~$118,931) Shares Retained: 106,905 Significance: Low (Routine Tax Withholding)

Comprehensive Analysis

Insider Transaction Summary

  • Issuer: Roivant Sciences Ltd. (ROIV)
  • Insider: James C. Momtazee (Director)
  • Filing Date: September 14, 2026
  • Transaction Date: September 10, 2026
  • Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)

Key Details

  • Shares Disposed: 2,905 Common Shares
  • Price per Share: $40.94
  • Total Value: $118,930.70
  • Post-Transaction Holdings: 106,905 Direct Shares

Context & Significance

This disposition represents a routine net settlement by the issuer to satisfy tax withholding obligations triggered by the vesting of previously granted Common Shares under the Non-Employee Director Compensation Plan. Because this is a non-discretionary transaction driven by statutory tax obligations rather than an open-market sale, it holds Low trading significance.

Topics:#ROIV#RoivantSciences#InsiderTrading#Form4#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.